Increased expression of Sox2 was observed in CD133+ NSCLC cells70 and ALDHhigh cells.71 Zhu and colleagues72 showed that Sox2 is a marker for CSCs in bladder cancer. This evidence concerns the gene SOX2 and urinary bladder cancer.